160 related articles for article (PubMed ID: 21638024)
21. Identification of novel low molecular weight serum peptidome biomarkers for non-small cell lung cancer (NSCLC).
Yang J; Song YC; Song TS; Hu XY; Guo YM; Li ZF; Dang CX; Huang C
J Clin Lab Anal; 2012 May; 26(3):148-54. PubMed ID: 22628229
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive proteome analysis of ovarian cancers using liquid phase separation, mass mapping and tandem mass spectrometry: a strategy for identification of candidate cancer biomarkers.
Wang H; Kachman MT; Schwartz DR; Cho KR; Lubman DM
Proteomics; 2004 Aug; 4(8):2476-95. PubMed ID: 15274142
[TBL] [Abstract][Full Text] [Related]
23. Discrimination analysis of mass spectrometry proteomics for cervical cancer detection.
Liu C; Pan C; Shen J; Wang H; Yong L; Zhang R
Med Oncol; 2011 Dec; 28 Suppl 1():S553-9. PubMed ID: 21080108
[TBL] [Abstract][Full Text] [Related]
24. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.
Freed GL; Cazares LH; Fichandler CE; Fuller TW; Sawyer CA; Stack BC; Schraff S; Semmes OJ; Wadsworth JT; Drake RR
Laryngoscope; 2008 Jan; 118(1):61-8. PubMed ID: 18043497
[TBL] [Abstract][Full Text] [Related]
25. Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies.
Timms JF; Arslan-Low E; Kabir M; Worthington J; Camuzeaux S; Sinclair J; Szaub J; Afrough B; Podust VN; Fourkala EO; Cubizolles M; Kronenberg F; Fung ET; Gentry-Maharaj A; Menon U; Jacobs I
Proteomics Clin Appl; 2014 Dec; 8(11-12):982-93. PubMed ID: 25290619
[TBL] [Abstract][Full Text] [Related]
26. The ascites N-glycome of epithelial ovarian cancer patients.
Biskup K; Braicu EI; Sehouli J; Tauber R; Blanchard V
J Proteomics; 2017 Mar; 157():33-39. PubMed ID: 28188862
[TBL] [Abstract][Full Text] [Related]
27. Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
Leiserowitz GS; Lebrilla C; Miyamoto S; An HJ; Duong H; Kirmiz C; Li B; Liu H; Lam KS
Int J Gynecol Cancer; 2008; 18(3):470-5. PubMed ID: 17655680
[TBL] [Abstract][Full Text] [Related]
28. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of systemic lupus erythematosus.
Huang Z; Shi Y; Cai B; Wang L; Wu Y; Ying B; Qin L; Hu C; Li Y
Rheumatology (Oxford); 2009 Jun; 48(6):626-31. PubMed ID: 19389822
[TBL] [Abstract][Full Text] [Related]
29. Biomarker discovery for ovarian cancer using SELDI-TOF-MS.
Zhang H; Kong B; Qu X; Jia L; Deng B; Yang Q
Gynecol Oncol; 2006 Jul; 102(1):61-6. PubMed ID: 16403569
[TBL] [Abstract][Full Text] [Related]
30. [Serum proteome profiling for ovarion cancer diagnosis using ClinProt magnetic bead technique and MALDI-TOF-mass-spectrometry].
Ziganshin RKh; Alekseev DG; Arapidi GP; Ivanov VT; Moshkovskiĭ SA; Govorun VM
Biomed Khim; 2008; 54(4):408-19. PubMed ID: 18988457
[TBL] [Abstract][Full Text] [Related]
31. Mass spectrometric screening of ovarian cancer with serum glycans.
Kim JH; Park CW; Um D; Baek KH; Jo Y; An H; Kim Y; Kim TJ
Dis Markers; 2014; 2014():634289. PubMed ID: 24648610
[TBL] [Abstract][Full Text] [Related]
32. Proteomic studies of early-stage and advanced ovarian cancer patients.
Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
[TBL] [Abstract][Full Text] [Related]
33. Identification of ovarian cancer-associated proteins in symptomatic women: A novel method for semi-quantitative plasma proteomics.
Shield-Artin KL; Bailey MJ; Oliva K; Liovic AK; Barker G; Dellios NL; Reisman S; Ayhan M; Rice GE
Proteomics Clin Appl; 2012 Apr; 6(3-4):170-81. PubMed ID: 22532453
[TBL] [Abstract][Full Text] [Related]
34. [Study for drug-resistance of epithelial ovarian cancer by serum protein profiling].
Zhang WY; Zhu LR; Zheng YH; Zhou L; Zhang JZ; Wu JH; Liao QP
Zhonghua Yi Xue Za Zhi; 2009 May; 89(19):1326-9. PubMed ID: 19615186
[TBL] [Abstract][Full Text] [Related]
35. Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer.
Clarke CH; Yip C; Badgwell D; Fung ET; Coombes KR; Zhang Z; Lu KH; Bast RC
Gynecol Oncol; 2011 Sep; 122(3):548-53. PubMed ID: 21708402
[TBL] [Abstract][Full Text] [Related]
36. Identification of serum biomarkers for lung cancer using magnetic bead-based SELDI-TOF-MS.
Song QB; Hu WG; Wang P; Yao Y; Zeng HZ
Acta Pharmacol Sin; 2011 Dec; 32(12):1537-42. PubMed ID: 22019958
[TBL] [Abstract][Full Text] [Related]
37. Alterations in the serum proteome profile during the development of ovarian cancer.
Sun L; Li L; Li Z; Hong S; Yang Q; Qu X; Kong B
Int J Oncol; 2014 Dec; 45(6):2495-501. PubMed ID: 25340615
[TBL] [Abstract][Full Text] [Related]
38. Effect of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry on identifying biomarkers of laryngeal carcinoma.
Liu C; Pan C; Wang H; Yong L
Tumour Biol; 2011 Dec; 32(6):1139-45. PubMed ID: 21826475
[TBL] [Abstract][Full Text] [Related]
39. Proteomic biomarker identification for diagnosis of early relapse in ovarian cancer.
Oh JH; Nandi A; Gurnani P; Knowles L; Schorge J; Rosenblatt KP; Gao JX
J Bioinform Comput Biol; 2006 Dec; 4(6):1159-79. PubMed ID: 17245808
[TBL] [Abstract][Full Text] [Related]
40. Identification and validation of salivary proteomic signatures for non-invasive detection of ovarian cancer.
Tajmul M; Parween F; Singh L; Mathur SR; Sharma JB; Kumar S; Sharma DN; Yadav S
Int J Biol Macromol; 2018 Mar; 108():503-514. PubMed ID: 29222021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
